According to a fresh study.

Duff told the paper that’s because searching at brains of individuals who died with Alzheimer’s is similar to searching at a wrecked car and trying to find out the accident’s cause. The analysis authors hope their brand-new findings may be used to improve treatments now. If, as our data recommend, tau pathology begins in the entorhinal cortex and hails from there, the most effective strategy may be to treat Alzheimer’s the way we treat malignancy – through early recognition and treatment, before a possibility is had because of it to spread, study co-author Dr. Scott A. Small, professor of neurology at the Columbia University Medical Center, said in the declaration. It is in this early stage that the disease will end up being most amenable to treatment.Under the contract, Biogen Idec will receive the exclusive worldwide license to build up and commercialize Amorfix’s Disease Particular Epitopes ) antibodies for ALS while Amorfix retains all privileges for diagnostics. Amorfix received an up-front payment of US$1 million and can be permitted receive milestone payments and royalties on sales. In June 2010, the ongoing company and Pan-Provincial Vaccine Business Inc. of Saskatoon, Saskatchewan, announced that the two groups have entered right into a licensing agreement granting PREVENT unique worldwide rights to Amorfix’s business lead amyotrophic lateral sclerosis vaccines.